Insulet (PODD) Net Margin Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn | 531.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 531.00 |
| Dec 31, 2025 | 838.00 |
| Sep 30, 2025 | 1,393.00 |
| Jun 30, 2025 | 1,516.00 |
| Mar 31, 2025 | -502.00 |
| Dec 31, 2024 | 792.00 |
| Sep 30, 2024 | 968.00 |
| Jun 30, 2024 | 4,823.00 |
| Dec 31, 2023 | 2,723.00 |
| Sep 30, 2023 | 704.00 |
| Jun 30, 2023 | 52.00 |
| Mar 31, 2023 | 771.00 |
| Dec 31, 2022 | 221.00 |
| Sep 30, 2022 | -194.00 |
| Jun 30, 2022 | -1,248.00 |
| Mar 31, 2022 | 850.00 |
| Dec 31, 2021 | 293.00 |
| Sep 30, 2021 | 347.00 |
| Jun 30, 2021 | -826.00 |
| Dec 31, 2019 | 235.00 |
| Sep 30, 2019 | 48.00 |
| Jun 30, 2019 | 62.00 |
| Mar 31, 2019 | 496.00 |
| Dec 31, 2018 | 1,963.00 |
| Sep 30, 2018 | 242.00 |
| Jun 30, 2018 | -439.00 |
| Mar 31, 2018 | -240.00 |
| Dec 31, 2016 | 368.00 |
| Sep 30, 2016 | 3,478.00 |
| Jun 30, 2016 | 1,768.00 |
| Mar 31, 2016 | 1,639.00 |
| Dec 31, 2015 | 400.00 |
| Sep 30, 2015 | 2,136.00 |
| Jun 30, 2015 | 3,140.00 |
| Mar 31, 2015 | 2,806.00 |
| Dec 31, 2014 | 2,785.00 |
| Sep 30, 2014 | 1,595.00 |
| Jun 30, 2014 | -1,533.00 |
| Mar 31, 2014 | 2,597.00 |
| Dec 31, 2013 | 7,147.00 |
| Sep 30, 2013 | 1,269.00 |
| Jun 30, 2013 | 4,227.00 |